[Treatment of peritoneal carcinosis of colorectal origin].
Dubé
P
P
Département de Chirurgie Générale Carcinologique, Institut Gustave-Roussy, Villejuif.
Lasser
P
P
Elias
D
D
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002277:Carcinoma / Q000473:pathology / Q000503:physiopathology / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000473:pathology*; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D007274:Injections, Intraperitoneal; D007430:Intraoperative Care; D010534:Peritoneal Neoplasms / Q000503:physiopathology / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D012004:Rectal Neoplasms / Q000473:pathology*
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil
Traitement de la carcinose péritonéale d'origine colorectale.